Immunovaccine and Incyte Expand Clinical Collaboration Evaluating Combination Immunotherapies in Advanced Recurrent Ovarian Cancer

    NEXT STORY
    ADMA Biologics Announces the Release of its First Commercial Batch of Nabi-HB Manufactured Under its Ownership
    PREV STORY
    Axsome Therapeutics Hosts R&D Day Today with Key Opinion Leaders Focusing on AXS-05 and Unmet Needs in Depression, Alzheimer’s Disease Agitation, and Nicotine Dependence
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Infectious Disease Diagnostics Market Worth $12.88 Billion by 2025- Exclusive Report by Meticulous Research®

    author_avatar
    NASDAQ Market News

    Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration

    Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive ...

    author_avatar
    NASDAQ Market News

    Cidara Therapeutics to Present at Two Upcoming Conferences

    SAN DIEGO, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology ...

    author_avatar
    NASDAQ Market News